Genomic profiling of newly diagnosed glioblastoma patients and its potential for clinical utility – a prospective, translational study

Glioblastoma (GBM) is an incurable brain tumor for which new treatment strategies are urgently needed. Next‐generation sequencing of GBM has most often been performed retrospectively and on archival tissue from both diagnostic and relapse surgeries with limited knowledge of clinical information, inc...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Dorte S. Nørøxe, Christina W. Yde, Olga Østrup, Signe R. Michaelsen, Ane Y. Schmidt, Savvas Kinalis, Mathias H. Torp, Jane Skjøth‐Rasmussen, Jannick Brennum, Petra Hamerlik, Hans S. Poulsen, Finn C. Nielsen, Ulrik Lassen
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Wiley 2020-11-01
Sarja:	Molecular Oncology
Aiheet:	chromosomal instability genomic profiling newly diagnosed glioblastoma NTRK fusion translational relevance tumor mutational burden
Linkit:	https://doi.org/10.1002/1878-0261.12790
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!